OLABODE OLUMOFIN: Open Payments
NPI 1720025513 · PINE BLUFF, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 15 payments from 6 companies in 2025. Trend: 2023 $685 · 2024 $848 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $139 |
| SANOFI-AVENTIS U.S. LLC | 1 | $77 |
| ViiV Healthcare Company | 1 | $76 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $70 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| ABBVIE INC. | 1 | $18 |
Products named: CAPLYTA, TZIELD, APRETUDE, VERQUVO, UBRELVY.
Industry payments across AR — which companies pay providers there.
